新型冠状病毒肺炎患者肠内营养药学服务路径  

Pharmacy Services Pathway of Enteral Nutrition for Patients with Corona Virus Disease 2019

作　　者：李璐璐[1] 杨香瑜[1] 董俊丽[1] 郭珩[1] 张韶辉[1] Li Lulu;Yang Xiangyu;Dong Junli;Guo Heng;Zhang Shaohui(Wuhan No.1 Hospital,Wuhan 430022,China)

机构地区：[1]武汉市第一医院,武汉430022

出　　处：《中国药师》2020年第8期1578-1581,共4页China Pharmacist

摘　　要：营养支持作为基础治疗手段,是新型冠状病毒肺炎(COVID-19)患者综合治疗措施的核心内容。为了进一步提高COVID-19患者的营养治疗效果,本文结合营养支持相关原则,推荐个体化营养治疗方案,并在实践基础上建立COVID-19患者肠内营养药学服务路径、肠内制剂选择路径,促进药学服务的规范化。As a basic treatment,nutritional therapy is the core content of comprehensive treatment measures for patients with Corona Virus Disease 2019( COVID-19). This paper aimed to provide recommendations to improve the effect of nutrition therapy among COVID-19 patients. According to the main principles of nutritional support therapy,individualized nutritional therapy was recommended and elaborated for COVID-19 patients in the paper. Based on the practice,a standardized pharmacy services pathway of enteral nutrition( EN) therapy for COVID-19 and a choice of pathway EN preparations was established. Meanwhile,the standardization of pharmaceutical care was improved.

关 键 词：新型冠状病毒肺炎 肠内营养 药学服务路径 

分 类 号：R97[医药卫生—药品]